Literature DB >> 18694561

Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation.

Sara Sigismund1, Elisabetta Argenzio, Daniela Tosoni, Elena Cavallaro, Simona Polo, Pier Paolo Di Fiore.   

Abstract

Clathrin-mediated endocytosis (CME) is the major pathway of epidermal growth factor receptor (EGFR) internalization. It is commonly believed that CME mediates long-term attenuation of EGFR signaling by targeting the receptor for degradation. However, the EGFR can also be internalized through (a) clathrin-independent pathway(s), and it remains unclear why distinct mechanisms of internalization have evolved. Here, we report that EGFRs internalized via CME are not targeted for degradation, but instead are recycled to the cell surface. By contrast, clathrin-independent internalization preferentially commits the receptor to degradation. This finding has profound implications for signaling, as by skewing EGFR fate toward recycling rather than degradation, CME prolongs the duration of signaling. Our data show that CME determines the longevity of some EGFR-activated signaling pathways and that EGF-dependent biological responses, such as DNA synthesis, absolutely require CME. Thus, CME of the EGFR unexpectedly has a greater impact on receptor signaling than on receptor degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694561     DOI: 10.1016/j.devcel.2008.06.012

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  298 in total

1.  Sortilin regulates progranulin action in castration-resistant prostate cancer cells.

Authors:  Ryuta Tanimoto; Alaide Morcavallo; Mario Terracciano; Shi-Qiong Xu; Manuela Stefanello; Simone Buraschi; Kuojung G Lu; Demetrius H Bagley; Leonard G Gomella; Katia Scotlandi; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

Review 2.  Signaling endosomes: seeing is believing.

Authors:  Marta Miaczynska; Dafna Bar-Sagi
Journal:  Curr Opin Cell Biol       Date:  2010-06-09       Impact factor: 8.382

3.  Sensitivity control through attenuation of signal transfer efficiency by negative regulation of cellular signalling.

Authors:  Yu Toyoshima; Hiroaki Kakuda; Kazuhiro A Fujita; Shinsuke Uda; Shinya Kuroda
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

Review 4.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

5.  Effects of loss of myosin VI no-insert isoform on clathrin-mediated endocytosis of plasma-membrane receptors.

Authors:  Claudia Puri
Journal:  Commun Integr Biol       Date:  2010-05

Review 6.  The endocytic matrix.

Authors:  Giorgio Scita; Pier Paolo Di Fiore
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

7.  Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.

Authors:  Rulla M Tamimi; Graham A Colditz; Yihong Wang; Laura C Collins; Rong Hu; Bernard Rosner; Hanna Y Irie; James L Connolly; Stuart J Schnitt
Journal:  Breast Cancer Res Treat       Date:  2011-01-01       Impact factor: 4.872

Review 8.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

Review 9.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 10.  New Player in Endosomal Trafficking: Differential Roles of Smad Anchor for Receptor Activation (SARA) Protein.

Authors:  Victoria Rozés-Salvador; Sebastian O Siri; Melina M Musri; Cecilia Conde
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.